Xvivo Perfusion
504 SEK +2,44%2 investorer følger denne virksomhed
Xvivo Perfusion is a medical technology company. The company provides solutions for lung transplantation. Examples of products that the company delivers include needles, organ storage, and cooling solutions. The products are resold to clinics and research institutes around the global market, with the largest business presence in the Nordics and Europe. The company was established via a spin-off from Vitrolife in 2012 and is headquartered in Gothenburg.
Omsætning
597,54 mio.
EBIT %
0,7 %
P/E
164,17
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
XVIVO
Daglig lav / høj pris
491,5 / 504
SEK
Markedsværdi
15,88 mia. SEK
Aktieomsætning
6,72 mio. SEK
Volumen
14 t
Seneste videoer
Finanskalender
Delårsrapport
24.10.2024
Årsrapport
28.01.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Bure Equity | 14,3 % | 14,3 % |
Fjärde AP-fonden | 8,6 % | 8,6 % |
Eccenovo AB | 5,8 % | 5,8 % |
Swedbank Robur Funds | 5,2 % | 5,2 % |
Handelsbanken Fonder | 4,9 % | 4,9 % |
Capital Group | 2,8 % | 2,8 % |
Första AP-fonden | 2,6 % | 2,6 % |
Premier Miton Investors | 2,3 % | 2,3 % |
Andra AP-fonden | 1,9 % | 1,9 % |
Nordnet Pensionsförsäkring | 1,3 % | 1,3 % |
ViserAlle indholdstyper
XVIVO to acquire a unique communication platform for the transplant process
Nomination Committee of XVIVO Perfusion AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools